Australia TGA ARTG record

Excilor Warts 2 in 1 Warts Treatment - Wart cryogenic kit

Australia TGA ARTG Registered Device · Actor Pharmaceuticals Pty Ltd · Medical Brands Innovations BV · Class IIa · Started December 17, 2019

Good Name: Actor Pharmaceuticals Pty Ltd - Excilor Warts 2 in 1 Warts Treatment - Wart cryogenic kit

Device classification

Risk Class: Class IIa
Product Type: Medical device system
ARTG Category: General

Registration information

Start Date: December 17, 2019
Effective Date: December 17, 2019

Sponsor

Name: Actor Pharmaceuticals Pty Ltd

Manufacturer

Name: Medical Brands Innovations BV
Country: Netherlands
Address: Piet Heinkade 199, Amsterdam, 1019HC

Intended purpose

Excilor Warts Treatment 2 in 1 (Cryo Acid combo) is intended to treat common warts (verruca vulgaris, usually located on hands and feet) and foot warts (verruca plantaris) in adults and children from 4 years old.

About this record

Access comprehensive regulatory information for Excilor Warts 2 in 1 Warts Treatment - Wart cryogenic kit in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Actor Pharmaceuticals Pty Ltd, manufactured by Medical Brands Innovations BV in Netherlands. The device registration started on December 17, 2019.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.